The most severe phenotype associated with SCN1A mutations is Dravet syndrome (DS; MIM#607208), which accounts for >80% epilepsy patients carrying SCN1A mutations. This evidence concerns the gene SCN1A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.